Inhaling medicines: delivering drugs to the body through the lungs.
about
Toxicology of nanomaterials used in nanomedicinePulmonary applications and toxicity of engineered nanoparticlesMeasurements of Deposition, Lung Surface Area and Lung Fluid for Simulation of Inhaled CompoundsInfluence of physical properties of carrier on the performance of dry powder inhalersDiesel exhaust: current knowledge of adverse effects and underlying cellular mechanismsInhaled nano- and microparticles for drug deliveryNano-Therapeutics for the Lung: State-of-the-Art and Future PerspectivesNovel formulations for antimicrobial peptidesAn overview of clinical and commercial impact of drug delivery systemssiRNA delivery to the lung: what's new?Delivery of RNAi Therapeutics to the Airways-From Bench to BedsideAirway Epithelial Cell Cilia and Obstructive Lung DiseaseThe neonatal Fc receptor, FcRn, as a target for drug delivery and therapyInteraction and localization of synthetic nanoparticles in healthy and cystic fibrosis airway epithelial cells: effect of ozone exposureInhaled Antibiotics for Gram-Negative Respiratory InfectionsTargeted Lung Delivery of Nasally Administered AerosolsParticle dynamics and deposition in true-scale pulmonary acinar models.Particle transport and deposition: basic physics of particle kineticsIsoxyl aerosols for tuberculosis treatment: preparation and characterization of particlesCharacterization of protein factor(s) in rat bronchoalveolar lavage fluid that enhance insulin transport via transcytosis across primary rat alveolar epithelial cell monolayersA cell-based computational modeling approach for developing site-directed molecular probesThe interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticlesMetabolic hormones, apolipoproteins, adipokines, and cytokines in the alveolar lining fluid of healthy adults: compartmentalization and physiological correlatesPhysicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein coronaThe role of disposable inhalers in pulmonary drug delivery.Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platformFaraday instability-based micro droplet ejection for inhalation drug delivery.Pharmaceutical particle engineering via spray drying.Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo DataNanomedicine in pulmonary deliveryPolymeric nanocarriers for transport modulation across the pulmonary epithelium: dendrimers, polymeric nanoparticles, and their nanoblendsThe effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma.Inhaled insulin: overview of a novel route of insulin administration.Poly(amidoamine) dendrimer nanocarriers and their aerosol formulations for siRNA delivery to the lung epithelium.Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.Chemosensory functions for pulmonary neuroendocrine cellsInhalable sustained-release formulation of glucagon: in vitro amyloidogenic and inhalation properties, and in vivo absorption and bioactivity.Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents.Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.Advances in device and formulation technologies for pulmonary drug delivery.
P2860
Q23914977-F0AC54D6-C564-4665-8B7F-CAEAFD7F9BB8Q24650775-12A68092-F47F-48AB-AAD2-646271E45F11Q26738341-3B43817A-1CBF-4467-81D3-C350F58F57B6Q26740570-76809074-60E4-4957-8F0E-27B28F9C8ACDQ26750759-F0EAB005-8239-47A3-A883-38C8B9B7F7E6Q26771328-183E2840-FC45-4D77-B59A-8F3EA1A25D98Q26786162-6EE7DAE2-A352-4D99-BAF1-59E3079B315FQ26991771-9C8327B9-A7BC-43F9-9814-76E3EA99FF72Q27007143-F709876F-03C1-4FD7-82F3-6717902BD896Q27022043-EFC55EA9-15D0-4C91-A562-4E0392A873C1Q28067306-EF512D25-EBBF-497E-9ACC-CB76F985A90BQ28074301-D5D01943-6059-45E1-8603-532EDD99E456Q28257521-115BD45E-6156-4A70-B2E8-BF7CA94C5961Q28382811-0D6FC717-A0B4-4A5F-85E8-372CDFF0C98EQ28386160-B6287C57-BB47-4493-9D08-29F93C2EBF2CQ28387568-6FCE28C1-9CC9-4A9F-90B7-C24EB3632C08Q28388343-D0DDFCD8-AB4F-49BF-AE56-837D1E71B6EAQ28391883-BBD19BF5-93D5-4EBB-A87F-211E800CFD76Q28396917-921F5649-3308-47D9-850B-602C87311C39Q28397450-BF0611F7-5395-4E3B-9921-7C7FA865179EQ28481186-269ECABD-EA16-4693-BD77-A93CE949E8C1Q28481207-B5DFA6EC-F51F-491E-8B34-41402DAB5DA7Q28545780-FBF4E372-A1BD-42FA-99CD-26138128C047Q29248541-9A0B0DFC-0F24-4AC4-B1FC-DD62B822C954Q30368417-4811F196-A787-41CB-84AA-6EC821411572Q30386192-405B9CC3-D75E-4D03-8549-F6E3774A76A3Q30434801-9B72A2C1-FCB5-4F4E-86A3-A7E8AA109672Q30496354-10115A57-C1A7-48AF-9D86-CA58E2ACE2D9Q30945192-AD9908E3-CF74-4A3A-8D18-5A12263E352CQ33572981-766B3231-57D8-4CC3-8E4A-1B1011BEF8CEQ33574188-2A8797C3-9C84-413F-BBF4-26856F7B80C3Q33692813-2EDB3DAD-A7AF-4E2D-B8F2-427B269E6696Q33715395-B51DD9B8-3BA1-4752-A9EB-637409813E8AQ33732559-3B377B46-EA74-4457-BE31-8800B1595CF1Q33792946-45F42941-A7E9-4677-9D6E-72E191795C3BQ33799656-00B34FA8-44A9-4902-8575-DC29AD04AAB0Q33810383-BBCC2EAA-5335-4680-96A5-B25E32214BD4Q33835121-63C572C4-E23D-45AA-80F5-F6A727EAF4B4Q33846935-87C209C3-5905-4152-A6E5-C49B267D71DDQ33962567-8ECD45A7-3B87-403A-BF5B-C3E7CC0EC1B6
P2860
Inhaling medicines: delivering drugs to the body through the lungs.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inhaling medicines: delivering drugs to the body through the lungs.
@ast
Inhaling medicines: delivering drugs to the body through the lungs.
@en
type
label
Inhaling medicines: delivering drugs to the body through the lungs.
@ast
Inhaling medicines: delivering drugs to the body through the lungs.
@en
prefLabel
Inhaling medicines: delivering drugs to the body through the lungs.
@ast
Inhaling medicines: delivering drugs to the body through the lungs.
@en
P2860
P356
P1476
Inhaling medicines: delivering drugs to the body through the lungs.
@en
P2093
John S Patton
Peter R Byron
P2860
P2888
P356
10.1038/NRD2153
P577
2007-01-01T00:00:00Z